These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

317 related articles for article (PubMed ID: 33436054)

  • 1. Comparative analysis of mouse bone marrow and adipose tissue mesenchymal stem cells for critical limb ischemia cell therapy.
    Nammian P; Asadi-Yousefabad SL; Daneshi S; Sheikhha MH; Tabei SMB; Razban V
    Stem Cell Res Ther; 2021 Jan; 12(1):58. PubMed ID: 33436054
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparative study of mouse adipose- and bone marrow mesenchymal stem cells in diabetic model with critical limb ischemia.
    Asadi-Yousefabad SL; Nammian P; Sheikhha MH; Tabei SMB; Daneshi S; Nikukar H; Lotfi M; Razban V
    Cell Tissue Bank; 2022 Dec; 23(4):923-936. PubMed ID: 35590084
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Self-assembled GFFYK peptide hydrogel enhances the therapeutic efficacy of mesenchymal stem cells in a mouse hindlimb ischemia model.
    Huang A; Liu D; Qi X; Yue Z; Cao H; Zhang K; Lei X; Wang Y; Kong D; Gao J; Li Z; Liu N; Wang Y
    Acta Biomater; 2019 Feb; 85():94-105. PubMed ID: 30550934
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vivo efficacy of endothelial growth medium stimulated mesenchymal stem cells derived from patients with critical limb ischemia.
    Al-Rifai R; Nguyen P; Bouland N; Terryn C; Kanagaratnam L; Poitevin G; François C; Boisson-Vidal C; Sevestre MA; Tournois C
    J Transl Med; 2019 Aug; 17(1):261. PubMed ID: 31399109
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bone marrow mesenchymal stem cell-derived endothelial cells increase capillary density and accelerate angiogenesis in mouse hindlimb ischemia model.
    Yao Z; Liu H; Yang M; Bai Y; Zhang B; Wang C; Yan Z; Niu G; Zou Y; Li Y
    Stem Cell Res Ther; 2020 Jun; 11(1):221. PubMed ID: 32513272
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A double blind randomized placebo controlled phase I/II study assessing the safety and efficacy of allogeneic bone marrow derived mesenchymal stem cell in critical limb ischemia.
    Gupta PK; Chullikana A; Parakh R; Desai S; Das A; Gottipamula S; Krishnamurthy S; Anthony N; Pherwani A; Majumdar AS
    J Transl Med; 2013 Jun; 11():143. PubMed ID: 23758736
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hypoxia pretreatment improves the therapeutic potential of bone marrow mesenchymal stem cells in hindlimb ischemia via upregulation of NRG-1.
    Peng X; Liang B; Wang H; Hou J; Yuan Q
    Cell Tissue Res; 2022 Apr; 388(1):105-116. PubMed ID: 35091805
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neovascularization capacity of mesenchymal stromal cells from critical limb ischemia patients is equivalent to healthy controls.
    Gremmels H; Teraa M; Quax PH; den Ouden K; Fledderus JO; Verhaar MC
    Mol Ther; 2014 Nov; 22(11):1960-70. PubMed ID: 25174586
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Human bone marrow-derived, pooled, allogeneic mesenchymal stromal cells manufactured from multiple donors at different times show comparable biological functions in vitro, and in vivo to repair limb ischemia.
    Thej C; Balasubramanian S; Rengasamy M; Walvekar A; Swamynathan P; Raj SS; Shahani P; Siddikuzzaman ; Kolkundkar U; Seetharam RN; Gupta PK; Majumdar AS
    Stem Cell Res Ther; 2021 May; 12(1):279. PubMed ID: 33971964
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Angiogenesis in diabetic mouse model with critical limb ischemia; cell and gene therapy.
    Asadi-Yousefabad SL; Nammian P; Tabei SMB; Daneshi S; Fallahi J; Razban V; Sheikhha MH
    Microvasc Res; 2022 May; 141():104339. PubMed ID: 35151721
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Emerging roles of mesenchymal stem cell therapy in patients with critical limb ischemia.
    Shirbaghaee Z; Hassani M; Heidari Keshel S; Soleimani M
    Stem Cell Res Ther; 2022 Sep; 13(1):462. PubMed ID: 36068595
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy and Safety of Autologous Cell-based Therapy in Patients with No-option Critical Limb Ischaemia: A Meta-Analysis.
    Wahid FSA; Ismail NA; Wan Jamaludin WF; Muhamad NA; Mohamad Idris MA; Lai NM
    Curr Stem Cell Res Ther; 2018; 13(4):265-283. PubMed ID: 29532760
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Profound Actions of an Agonist of Growth Hormone-Releasing Hormone on Angiogenic Therapy by Mesenchymal Stem Cells.
    Ma Q; Xia X; Tao Q; Lu K; Shen J; Xu Q; Hu X; Tang Y; Block NL; Webster KA; Schally AV; Wang J; Yu H
    Arterioscler Thromb Vasc Biol; 2016 Apr; 36(4):663-672. PubMed ID: 26868211
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expansion and angiogenic potential of mesenchymal stem cells from patients with critical limb ischemia.
    Brewster L; Robinson S; Wang R; Griffiths S; Li H; Peister A; Copland I; McDevitt T
    J Vasc Surg; 2017 Mar; 65(3):826-838.e1. PubMed ID: 26921003
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hepatocyte growth factor gene-modified bone marrow-derived mesenchymal stem cells transplantation promotes angiogenesis in a rat model of hindlimb ischemia.
    Su GH; Sun YF; Lu YX; Shuai XX; Liao YH; Liu QY; Han J; Luo P
    J Huazhong Univ Sci Technolog Med Sci; 2013 Aug; 33(4):511-519. PubMed ID: 23904370
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rationale and design of the SAIL trial for intramuscular injection of allogeneic mesenchymal stromal cells in no-option critical limb ischemia.
    Wijnand JGJ; Teraa M; Gremmels H; van Rhijn-Brouwer FCC; de Borst GJ; Verhaar MC;
    J Vasc Surg; 2018 Feb; 67(2):656-661. PubMed ID: 29242062
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Xenotransplantation of neonatal porcine bone marrow-derived mesenchymal stem cells improves murine hind limb ischemia through lymphangiogenesis and angiogenesis.
    Yamada H; Sakata N; Nishimura M; Tanaka T; Shimizu M; Yoshimatsu G; Kawakami R; Wada H; Sawamoto O; Matsumoto S; Kodama S
    Xenotransplantation; 2021 Jul; 28(4):e12693. PubMed ID: 33960029
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transplantation of mesenchymal cells rejuvenated by the overexpression of telomerase and myocardin promotes revascularization and tissue repair in a murine model of hindlimb ischemia.
    Madonna R; Taylor DA; Geng YJ; De Caterina R; Shelat H; Perin EC; Willerson JT
    Circ Res; 2013 Sep; 113(7):902-14. PubMed ID: 23780385
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Augmentation of neovascularization in murine hindlimb ischemia by combined therapy with simvastatin and bone marrow-derived mesenchymal stem cells transplantation.
    Li Y; Zhang D; Zhang Y; He G; Zhang F
    J Biomed Sci; 2010 Sep; 17(1):75. PubMed ID: 20846454
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Enhancing Retention of Human Bone Marrow Mesenchymal Stem Cells with Prosurvival Factors Promotes Angiogenesis in a Mouse Model of Limb Ischemia.
    Cortez-Toledo E; Rose M; Agu E; Dahlenburg H; Yao W; Nolta JA; Zhou P
    Stem Cells Dev; 2019 Jan; 28(2):114-119. PubMed ID: 30398391
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.